Originally Published by the Crohn’s & Colitis Foundation on their IBDVisible Blog on June 8th, 2022
By: Madhura Balasubramaniam & Tina Aswani-Omprakash
After two years of virtual programming due to COVID-19, Digestive Disease Week® (DDW) 2022 came back with a bang in San Diego, CA last month. There was a lot of research presented about various gastrointestinal and liver conditions and it was exhilarating to see and hear about all the latest developments in the inflammatory bowel disease (IBD) space. From emerging therapies to better understanding of psychosocial aspects of IBD in addition to the role of antibiotics in IBD as well as growing up with pets and the development of IBD, there is tremendous research being done to help improve our lives as patients. We were able to attend in person (Tina) and virtually (Madhura) and are excited to share some of what we learned with the IBD community.
To read more about DDW 2022, please visit the full blog post on the Crohn’s & Colitis Foundation’s IBDVisible Blog.
As patient advocates, we believe that evidence-based information is vital to patient education, empowerment, and ultimately better health outcomes. We were thrilled to be able to attend DDW 2022 to learn about the latest research and clinical practice advancements in IBD and make this information accessible to our IBD patient community. We are hopeful that there will be better quality of life for all of us with all this research being done.
Madhura Balasubramaniam is a patient advocate living with Crohn’s disease in India who attended DDW 2022 virtually. Tina Aswani-Omprakash is a patient advocate living with Crohn’s disease in the United States who attended DDW 2022 in person. They work together alongside many clinicians and patients to run the South Asian IBD Alliance and create credible patient education for the wider IBD community.
